Inhibition of BCR-ABL gene expression and induction of apoptosis of K562 cell lines by siRNAs
Yanbin Song, Wenli Ma, Chun-Qiong Feng, Xiangming Mao, Rong Shi, Zhang Bao, Zheng Wen-ling
Abstract
Yanbin Song, Wenli Ma, Chun-Qiong Feng, Xiangming Mao, Rong Shi, Zhang Bao, Zheng Wen-ling
Abstract
Objective To study the inhibitory effect of BCR-ABL gene expression of K562 cell lines by RNAi technology.Methods Designing siRNAs targeting the breakpoint of BCR-ABL mRNA and transfecting K562 cells with lipofectamine~(TM) 2000,the inhibitory effect was observed by dedecting MTT、RT-PCR and FACS.Results The BCR-ABL expression obviously decreased and K562 cells had distinct apoptosis rate.Conclusions RNAi technology can inhibit BCR-ABL expression and induce apoptosis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the inhibitory effect of BCR-ABL gene expression of K562 cell lines by RNAi technology.Methods Designing siRNAs targeting the breakpoint of BCR-ABL mRNA and transfecting K562 cells with lipofectamine~(TM) 2000,the inhibitory effect was observed by dedecting MTT、RT-PCR and FACS.Results The BCR-ABL expression obviously decreased and K562 cells had distinct apoptosis rate.Conclusions RNAi technology can inhibit BCR-ABL expression and induce apoptosis.
Key concepts: K562 cells, RNA interference, Lipofectamine, Small interfering RNA, ABL, Apoptosis, breakpoint cluster region, Molecular biology